TEMAPHARM
Board
2 directors, since incorporationDirector (not named in the articles)
since 24-05-2019
listed in the 2025 annual accounts, filed on 25-06-2026
Director (not named in the articles)
since 24-05-2019
listed in the 2025 annual accounts, filed on 25-06-2026
Mandates through the years
2 names, the dashed line is todayBEAUJEAN Laurence Geneviève Dominique Marie
Director (not named in the articles)
Director (not named in the articles)
WERY Benoît Joseph Ghislain
Director (not named in the articles)
Director (not named in the articles)
Board
Mandates as a list
- BEAUJEAN Laurence Geneviève Dominique Marie
- Director (not named in the articles), from 24-05-2019 to date
- WERY Benoît Joseph Ghislain
- Director (not named in the articles), from 24-05-2019 to date
Control
This company
TEMAPHARM
Equity €71,330
Profit €84,991 in 2025
Capital
- Contribution
- €6,200
- Shares
- 100
- Contribution per share
- €62
- Equity per share
- €713 in 2025
- Source
- deed of 28-05-2019
Articles of association
deed of 28-05-2019 (in French)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- “Article 27. Droit commun. Les dispositions du Code des sociétés et des associations auxquelles il ne serait pas licitement dérogé sont…”
- Statutory auditorA statutory auditor is a registered auditor who checks the annual accounts. Small companies need not have one. According to the deed, the legal criteria do not require one here.
- No statutory auditor
- Liquidation ruleIn a liquidation the creditors are paid first. What is left goes to the shareholders.
- “Dissolution pour quelque cause et à quelque moment que ce soit, peut désigner un ou plusieurs liquidateurs et déterminer pouvoirs et…”
Shareholders
At incorporation
deed of 28-05-2019 ↗
- WERY Benoît Joseph Ghislain 50 shares (50%) · €3,100
- BEAUJEAN Laurence Geneviève Dominique Marie 50 shares (50%) · €3,100